|
Date of decision
|
04 July 2002
|
|
|
Case number
|
T 0694/01
- 3.3.4
|
|
|
Application number
|
88303744.2
|
|
|
|
|
|
|
Title of the application
|
Immunoassays and devices therefor
|
|
|
Applicant name
|
UNILEVER N.V.
|
|
|
Opponent name
|
(01) VEDALAB
(02) Carter-Wallace Inc.
(03) GENZYME CORPORATION
(04) Andrea von Preen
(05) Int. Mycoplasma
(06) Technical Chemicals & Products Inc.
(08) ORAMON Arzneimittel GmbH
(09) Pharma Peter
(10) ulti med Products (Deutschland)
(11) Cardimac Gesellschaft für Diagnostische Schnellteste mbH
|
|
Headnote
An intervention is dependent on the extent to which
opposition/appeal proceedings are still pending.
Where a board has decided that a patent be maintained on the
basis of a given set of claims and a description to be adapted
thereto, in subsequent appeal proceedings confined to the issue
of the adaption of the description, the intervener cannot
challenge the res judicata effect of the previous board of
appeal decision by introducing a new ground for opposition.
|
|
|
Keywords
Intervention during pending appeal proceedings - admissibility
(yes)
New ground of opposition - void
Scope of appeal limited to adaption of description
Claims - res judicata
|
|
|
|
|
